Bank of America’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-45,013
Closed -$3.38M 7741
2015
Q3
$3.38M Buy
45,013
+18,054
+67% +$1.35M ﹤0.01% 3263
2015
Q2
$2.03M Buy
26,959
+25,279
+1,505% +$1.35M ﹤0.01% 3442
2015
Q1
$84K Sell
1,680
-2,321
-58% -$97.4K ﹤0.01% 5406
2014
Q4
$139K Buy
4,001
+843
+27% +$29.4K ﹤0.01% 5654
2014
Q3
$103K Sell
3,158
-5,029
-61% -$177K ﹤0.01% 5988
2014
Q2
$314K Sell
8,187
-8,032
-50% -$280K ﹤0.01% 5091
2014
Q1
$645K Sell
16,219
-7,955
-33% -$356K ﹤0.01% 4349
2013
Q4
$903K Buy
24,174
+24,002
+13,955% +$996K ﹤0.01% 4169
2013
Q3
$8K Sell
172
-7,922
-98% -$237K ﹤0.01% 7264
2013
Q2
$219K Buy
+8,094
New +$185K ﹤0.01% 5541

Bank of America's KYTH Position: Q4 2015 in Review

Bank of America sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 45,013 shares — an estimated $3.38M sold.

Bank of America first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $3.38M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Bank of America reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Bank of America sold 45,013 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.38M.
  • Bank of America first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Bank of America's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $3.38M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.